Establishment and characterization of a human intrahepatic cholangiocarcinoma cell line derived from an Italian patient
Autor: | Giuliana Cavalloni, Carmine Dell'Aglio, Francesco Leone, Chiara Varamo, Giovanna Chiorino, Laura Casorzo, Massimo Aglietta, Paola Bernabei, Caterina Peraldo-Neia |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2016 |
Předmět: |
0301 basic medicine
Homeobox protein NANOG Pathology medicine.medical_specialty Cancer Research Carcinogenicity Tests New cell line DNA Mutational Analysis Population Mutation Missense Mice SCID medicine.disease_cause Cholangiocarcinoma Proto-Oncogene Proteins p21(ras) 03 medical and health sciences 0302 clinical medicine SOX2 In vitro model Cell Movement Mice Inbred NOD In vivo Cell Line Tumor Animals Humans Medicine Intrahepatic cholangiocarcinoma education Intrahepatic Cholangiocarcinoma Comparative Genomic Hybridization education.field_of_study Mutation business.industry CD24 General Medicine Middle Aged medicine.disease Primary tumor 030104 developmental biology Bile Duct Neoplasms Italy 030220 oncology & carcinogenesis Cancer research Original Article Female business Neoplasm Transplantation |
Zdroj: | Tumour Biology |
Popis: | Biliary tract carcinoma is a rare malignancy with multiple causes, which underlie the different genetic and molecular profiles. Cancer cell lines are affordable models, reflecting the characteristics of the tumor of origin. They represent useful tools to identify molecular targets for treatment. Here, we established and characterized from biological, molecular, and genetic point of view, an Italian intrahepatic cholangiocarcinoma cell line (ICC), the MT-CHC01. MT-CHC01 cells were isolated from a tumor-derived xenograft. Immunophenotypical characterization was evaluated both at early and after stabilization passages. In vitro biological, genetic, and molecular features were also investigated. In vivo tumorigenicity was assessed in NOD/SCID mice. MT-CHC01cells retain epithelial cell markers, EPCAM, CK7, and CK19, and some stemness and pluripotency markers, i.e., SOX2, Nanog, CD49f/integrin-α6, CD24, PDX1, FOXA2, and CD133. They grow as a monolayer, with a population double time of about 40 h; they show a low migration and invasion potential. In low attachment conditions, they are able to form spheres and to growth in anchorage-independent manner. After subcutaneous injection, they retain in vivo tumorigenicity; the expression of biliary markers as CA19-9 and CEA were maintained from primary tumor. The karyotype is highly complex, with a hypotriploid to hypertriploid modal number (3n+/−) (52 to 77 chromosomes); low level of HER2 gene amplification, TP53 deletion, gain of AURKA were identified; K-RAS G12D mutation were maintained from primary tumor to MT-CHC01 cells. We established the first ICC cell line derived from an Italian patient. It will help to study either the biology of this tumor or to test drugs both in vitro and in vivo. Electronic supplementary material The online version of this article (doi:10.1007/s13277-015-4215-3) contains supplementary material, which is available to authorized users. |
Databáze: | OpenAIRE |
Externí odkaz: |